Antiinflammatory properties of mycophenolate mofetil in murine endotoxemia: inhibition of TNF-α and upregulation of IL-10 release

This publication has 22 references indexed in Scilit:

• Modulation by dantrolene of endotoxin‐induced interleukin‐10, tumour necrosis factor‐α and nitric oxide production in vivo and in vitro
  British Journal of Pharmacology, 1998
• Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia.
  Journal of Clinical Investigation, 1996
• Enhancement of endotoxin‐induced interleukin‐10 production by SR 31747A, a sigma ligand
  European Journal of Immunology, 1995
• MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTS
  Transplantation, 1995
• Tumor Necrosis Factor–α Regulates In Vivo Nitric Oxide Synthesis and Induces Liver Injury During Endotoxemia
  Hepatology, 1994
• Interleukin‐10 controls interferon‐γ and tumor necrosis factor production during experimental endotoxemia
  European Journal of Immunology, 1994
• Immunosuppressive and other Effects of Mycophenolic Acid and an Ester Prodrug, Mycophenolate Mofetil
  Immunological Reviews, 1993
• In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A.
  The Journal of Experimental Medicine, 1993
• Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.
  The Journal of Experimental Medicine, 1993
• Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of Endotoxin
  Science, 1985